04:10

What is staging and what are the different stages of breast cancer?

05:52

How do you treat Stage 3 lung cancer?

04:40

When is the best time to start durvalumab after chemoradiation? When is treatment response assessed?

08:33

What are the differences between a regular mammogram and tomosynthesis?

02:16

When performing a contralateral prophylactic mastectomy, is sentinel lymph node biopsy done (SLNB)?

02:31

Why is a boost delivered to the chest wall scar after mastectomy?

03:07

What is the role radiation therapy in controlling leptomeningeal disease?

04:02

What is short course whole breast radiation? What makes me a good candidate for this?

03:27

What is SBRT and when do you use it in your patients?

03:27

What is oligometastatic disease and when do you treat it?

03:59

What is brachytherapy?

03:54

What is a breath hold technique and why is it used?

03:06

What is a bolus and when is it used in radiation treatments?

06:05

What are the indications to treat with radiation therapy after mastectomy?

03:05

Patient Success Stories: Localized HER2+ Breast Cancer, Frank Vicini MD

04:27

Is there a role for proton beam therapy in breast cancer?

05:19

In N1 cancer with pathologic PR/CR after neoadjuvant chemotherapy, how is radiation involved?

03:19

If I undergo a lumpectomy, do I need to have radiation therapy?

02:36

I have N1mi disease. Do I need radiation therapy to my lymph nodes?

03:40

How does radiation therapy (RT) affect breast implants?

03:12

Are radiation treatments delivered differently for obese patients?

04:46

Who is a candidate for IORT?

02:44

When is lymphedema surveillance recommended? When are prophylactic lymphedema measures considered?

01:15

What should I look for when selecting a radiation oncologist?

03:15

Patient Success Stories: Metastatic Pancreatic Cancer, Michael Pishvaian MD

03:30

What partial breast regimens are appropriate?

02:50

What is the role of liver transplant and cancer directed therapy in cholangiocarcinoma?

03:05

Patient Success Stories: Cholangiocarcinoma, Michael Pishvaian MD

02:43

What is the role of tumor bed boost in patients with DCIS following breast conserving surgery?

02:30

Does treating H. Pylori decrease the risk of developing gastric cancer?

02:22

What is the appropriate duration of breast radiation therapy?

03:56

What are lifestyle and environmental issues that can increase risk of esophageal or gastric cancer?

01:39

What are the cardiac effects of left breast radiation?

03:59

What would you recommend to patients for prevention of pancreas cancer?

02:19

When is axillary dissection vs. lymph node irradiation considered in micrometastatic nodal disease?

03:39

What is the role of tumor bed boost simultaneously vs. sequentially with whole breast irradiation?

03:36

I have inflammatory breast cancer. Will I need radiation therapy?

01:49

How does your approach to breast radiation differ in elderly patients?

02:37

How does radiation affect cosmetic results and eligibility for breast reconstruction?

01:50

How do you protect the heart in patients receiving left breast radiation?

06:33

Claudin 18.2 Target for Gastric and GEJ Cancer with SPOTLIGHT and GLOW Clinical Trials

02:11

If endocrine therapy is omitted in early stage breast cancer, what is the role of radiation therapy?

06:58

Immunotherapy with Gastric and GEJ cancers: ATTRACTION-5 and Toripalimab Clinical Trials

02:05

Does your radiation strategy change in someone with breast implants?

12:53

Role of Chemo with Pancreatic cancer: NAPOLI-3, FOOTPATH, PREOPANC-1 and NORPACT-1 Clinical Trials

02:55

Does HER2 status impact radiation therapy recommendations?

08:38

Role of KRAS with Pancreatic cancer and CRC featuring KRYSTAL-1 and AMPLIFY-201 Clinical Trials

07:51

Chemo/Immunotherapy with Biliary Cancers: SWOG 1815, TOPAZ-1, Keynote-966 and IMbrave151 Trials

01:35

Can a breast ever be re-irradiated in the case of a second primary?

10:56

What is the difference between screening and diagnostic imaging?

10:39

Multimodality Treatment of Locally Advanced Rectal Cancer: PRODIGE 23 and PROSPECT Clinical Trials

05:53

HER2 Treatment of CRC and Biliary Cancers: DESTINY-CRC01 and MOUNTAINEER Clinical Trials

10:27

What is a total mesorectal excision, expected post-op course, and markers of quality resection?

15:28

What is Total Neoadjuvant Therapy for Rectal Cancer and which patients should undergo it?

08:25

What is the BIRADS system?

05:21

How do you manage locally recurrent rectal cancer?

06:58

What are the challenges of operating on the colon or rectum after radiation?

21:27

What patients with rectal cancer may be eligible for surveillance after neoadjuvant therapy?

07:28

What is the MammaPrint assay? What are its strengths and weaknesses?

01:48

How do you define superficially invasive anal SCC and what is the surgical management?